chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a consumer refers to herself a 65 year old female patient with hypertension, arthritis, allergy to CORTIZONE and allergy to PREVACID. On 29-MAR-2014, the patient was vaccinated with PNEUMOVAX 23 reported route "injection", 1 Dosage, reported lot # 1047955-00000712. Concomitant therapies included LEVAQUIN, prednisone and unspecified antibiotic. On 02-APR-2014, the patient experienced walking pneumonia with symptoms of 102 temperature, feeling ill and could not breathe. The patient was treated with PROAIR HFA (90), amoxicillin, promethazine and a nebulizer. Blood and urine tests were performed (results not provided). The patient sought medical attention with her physician. The patient also reported that on an unknown date, she had an unspecified allergic reaction to PREVACID. Action taken with PNEUMOVAX 23 was reported as "not reintroduced". The outcome of walking pneumonia with symptoms of 102 temperature, feeling ill and could not breathe was unknown. Causality was not reported. Additional information has been requested.
Itching and rash NOT at injection site: head, neck, arms, chest, stomach, legs  Rash is fairly fine, NOT hives. Pops up on various parts of body, itchy and mild burning. This is NOT a terrible side effect, but I thought it best to report.  It is not yet getting better or subsiding (got injection 5 days ago).
Patient was hospitalized for ileocecal intussusception that was able to be successfully reduced by air enema 5/25/2022.  Patient had a recurrence of ileocecal intussusception 5/26/2022 that required urgent surgical intervention.
1/26/21 @ 5PM C/O TINGLING ALL OVER BODY AND RIGHT EYE". DENIES ANY TROUBLE BREATHING OR SWALLOWING, NO EDEMA OF LIPS. A/0 X3, SKIN PINK W/D, RESP REG WITH EASE. 1/26/21 @ 5:15PM CLIENT STATES SYMPTOMS ARE THE SAME AND "WILL TAKE BENADRYL WHEN SHE GETS HOMEIF NEEDED". 1/27/21 @  9:25AM CLIENT STATES ALL SYMPTOMS HAVE RESOLVED.
My face went numb for several hours a day and a half after injection.  I also had extreme fatigue, headaches, and pain and swelling at the injection site for 7+ days.
Got his vaccination and still got the Shingles/Suspected vaccination failure; Still got the Shingles; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 17th Apr 2022 Reporter's Comments: This case was reported by a consumer via interactive digital media. The patient had his shingles vaccine and still got the shingles. Additional Supportive Information: This case was considered as suspected vaccination failure since details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles not given. The follow up would not be possible since no contact details provided.
?COVID arm? - red, painful, swollen, hot, itchy skin around injection site, about 3 inches in diameter. Painful to sleep on.
Pt. developed feeling of flushing and dizziness immediately after receiving the vaccine , then C/O palpitations and chest tightness a few minutes later at 6:14pm.  After vital signs were found to be stable and improving with reassurance her complaints resolved without medication or treatment.
Starting 06/16/2022, I woke up at 06:00AM with a sore throat. I did the at home test and it was negative. So, I got on the plane with a mask. I arrived at 03:00PM and felt even worse. Later, I had a headache, "on fire" sore throat, left earache and bad fatigue. I was so fatigued that evening. I know I broke a fever that evening because I could not get warm. I had chills and was shaking. The next morning I woke up and felt dizzy. I didn't know where I was and had to grasp the wall. I went to the bathroom and tested my temp (102.5) and (101.2). I went back to bed and at 08:00AM I called my doctor and they got me a telehealth visit. So, about 30 min before the visit I did my 2nd at home test which came back positive. So, I saw the doctor and she recommended I take PAXLOVID, isolate for 5 days and take ibuprofen. She also called me in an antibiotic for an ear infection and cough medicine. I could feel myself getting worse and becoming more fatigued and I was shaky, lethargic, had a headache and fever. I got the PAXLOVID and took it right away. 30 minutes after taking it I started feeling better and that feeling would come and go in waves. She gave me something for pain but I did not need it. I did develop a cough but it was never a phlegmy cough. I did need the cough medicine but not much. Saturday  06/18/2022, I started the antibiotic (possibly ciprofloxacin) for the ear infection because the ear pain would not stop. I was still taking the PAXLOVID at this time and I was coming out of it on 06/19/2022. I was more coherent and was feeling better by 06/20/2022. I finished the PAXLOVID as instructed and on 06/21/2022 I was feeling better. The only thing that I experienced after stopping the PAXLOVID was a runny nose and some sneezing which lasted for about 2 days then resolved. I have felt fine ever since.
COVID-19; COVID-19; Numbness in fingers; Congestion; MARKETING PROGRAM NOT AVAILABLE  This is a solicited report received from contactable reporter(s) (Consumer or other non HCP) for a sponsored program. The reporter is the patient. Other Case identifier(s): 22K-163-4244455-00 (Abbvie).  A 51 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administration date 11Aug2021 (Batch/Lot number: unknown) at the age of 51 years as dose 2, single and intramuscular, administration date 23Jul2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation; upadacitinib (RINVOQ), oral (Batch/Lot number: unknown) for rheumatoid arthritis. The patient's relevant medical history and concomitant medications were not reported. It was unknown if patient was enrolled in a covid-19 vaccine trial. The following information was reported: DRUG INEFFECTIVE (medically significant), outcome "unknown", COVID-19 (medically significant), outcome "recovering" and all described as "COVID-19"; HYPOAESTHESIA (non-serious), outcome "recovering", described as "Numbness in fingers"; NASAL CONGESTION (non-serious), outcome "recovering", described as "Congestion". Reported that the patient contracted covid two times. He was still healing and had some congestion as of 20Jan2022. It was unknown if patient was enrolled in a covid-19 vaccine trial. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: unknown result, notes: The patient contracted covid two times; unknown result, notes: The patient contracted covid two times. The action taken for upadacitinib was unknown.  The reporter's causality for events (numbness in fingers, Covid-19 and congestion) with the RINVOQ was not reported. The reporter's causality for events (numbness in fingers, Covid-19 and congestion) with the BNT162B2 was possible.  The lot number for bnt162b2 was not provided and will be requested during follow up.; Sender's Comments: Based on the information in the case report and a plausible temporal relationship, a possible causal association between the events and suspect drug BNT162B2 cannot be excluded.
This case was reported by a non-health professional via sales rep and described the occurrence of injection site pain in a male patient who received Shingrix for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than a year after receiving Shingrix, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was recovered/resolved. It was unknown if the reporter considered the injection site pain to be related to Shingrix. Additional details were provided as follows: The age at vaccination was not reported. After receiving Shingrix, the patient experienced local injection site pain that lasted for 2 days. This case has been linked with case US2018GSK155277, reported by same reporter for same patient for 2nd dose.
Reaction started 7-4-10 redness, skin indurated, large blisters 10 x 7 area. Hot, itching, aching.
States had chest tightness & hives after dose #1 & went to ER. Private physician & ER doctor told her to take diphenhydramine prior to 2nd dose, which she did.  After 2nd dose she experienced immediate itching, shaking, & difficulty with chest rightness. She took 25 mg. diphenhydramine & used her Albuterol inhaler. She was starting to feel dizzy. Epi-Pen given per person in First Aid. Client started to feel better. Her mother was here to drive her. Recommended that she go to her private physician. Released to go with mother. First Aid escorted her to her car.
chills; exhaustion; headache; This spontaneous case was reported by a patient and describes the occurrence of CHILLS (chills), FATIGUE (exhaustion) and HEADACHE (headache) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 009021a and 054c21a) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced CHILLS (chills), FATIGUE (exhaustion) and HEADACHE (headache). At the time of the report, CHILLS (chills) and HEADACHE (headache) outcome was unknown and FATIGUE (exhaustion) had not resolved.            No Concomitant and  treatment medications were provided.    This case was linked to MOD-2021-261508 (Patient Link).
I had a very high fever whole body was hot. I took an advil dual action before I went to sleep my fever went away by the morning also slight twitching on the front and back of my scalp not very bad slight twitching and in the morning it felt like little balls moving through my veins on my arms but it all went away by midday 11: 00 12:00 following day and now I'm fine fully vaccinated but I want to help so that why I wrote this. So someone else knows what too expect.
24 hours after vaccination - pt developed pain left side of chest/arm and couldn't take deep breath. Call on cell physician next day (48 hours after vaccine) and pt sent to ER. EKG, CXR, labs all OK in ER. Followed up w/ her cardiologist on 7/16/07. Diagnosed w/ Pleurisy and put on Naproxen 750mg BID.
patients wife calling to report that the patient had his first covid shot on 2/ 11/21.   2 days later the patient broke out in hives on top of his head, forehead, back of neck cheek bone area on the LT side swelled up  only lasted 2 days.
One week after the first vaccine, I had severe pain in my right arm.  I could barely lift it. applied ice and pain lessened...Then other events followed...My left wrist became swollen and red. then a day later the severe pain was in my left arm and I could barely lift it.  I then had a swollen right foot.  Podiatrist gave me a shot of cortisone but continued to have the pain and swelling...Shoulder pain returned.   2nd vaccine was 02/03/2021...Feb 10...both hands were stiff and I couldn?t open them...Then the shoulder pain in my right arm returned .  This lasted 4 days...with the most severe pain.
Right after administration the patient had heavy bleeding at the injection site, the site then bruised up over the next few weeks and is still sore. The patient had seen a nurse who thinks it may have been given a little too low on the arm. The patient is wondering if she should have another dose of the flu shot this year due to the bleeding at the site right after.
This spontaneous report as received from a health worker refers to an unspecified number of patients of unknown age and gender. No concurrent or historical conditions were reported. On an unknown date, the patients were vaccinated with a dose of varicella virus vaccine live (Merck) (lot # and expiration date were not reported) (route and dose were not reported) which was improperly stored. No concomitant medication was reported. No adverse effect was reported at the time of this report. Additional information has been requested. This is one of several reports from the same source.
Administer expired vaccine to 450 patients, after the manufacture date of expiration; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine to 450 patients, after the manufacture date of expiration) in a 60-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 070H21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 08-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 08-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine to 450 patients, after the manufacture date of expiration). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine to 450 patients, after the manufacture date of expiration) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  It was reported that vials had not undergone any temperature excursion.  Total of 173 doses were given from LOT 070H21A.  It was unknown when the vial was stored in refrigerator.  No treatment medications were provided.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2022: Live follow up received contain Non-Significant information include reporters details updated.
Patient is experiencing nerve pain. There is a jolting wave of pain every few minutes that starts at the injection site and goes down the arm into the palm of their hand.  This started 2 weeks after the second dose of the Pfizer covid vaccine was administered. Symptoms have progressed since then.
I develop PVCs about 11hrs post vaccination along with other common symptoms. PVCs have continued to present.  8 days post vaccination I developed chest pain with the PVCs.
at 2:40pm, patient reports dryness in her mouth, after she drank a little water, symptoms worsened and she reported her lips feeling numb.  She pre-medicated with Benadryl 25mg at home at 1:38pm.  At 2:49pm epi was administered.  Heart and lungs WNL.  History of tongue itchiness after 1st COVID-19 vaccine. Patient declined transport to ED for continued evaluation.
bad cough / it progressively got worse / coughs more than before; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (bad cough / it progressively got worse / coughs more than before) in a 19-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Jul-2021, the patient experienced COUGH (bad cough / it progressively got worse / coughs more than before). At the time of the report, COUGH (bad cough / it progressively got worse / coughs more than before) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported by reporter Treatment information was not provided
Donor reported a rash that developed on back, neck and arms. Rash cleared up the same day.
I felt sickish at stomach. Did not vomit but not hungry. Excessive amount of gas on stomach. Some coughing. My normal temperature is 96 or 97 but it measured 99 degrees then. This could have been a touch of something else but since it followed the shot, I felt that it was the probable source. I was also very tired. It lasted about 4 days.
diffuse urticaria developed within 24 hours of the vaccine, no anaphylaxis.
This case was reported by a other health professional via sales rep and described the occurrence of influenza-like symptoms in a adult male patient who received SHINGRIX for prophylaxis. In April 2018, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced influenza-like symptoms. On an unknown date, the outcome of the influenza-like symptoms was recovered/resolved. It was unknown if the reporter considered the influenza-like symptoms to be related to SHINGRIX. Additional information was reported as follows: The patient was a physician at the practice from where the reporter called to report the adverse event. The patient received his first dose in April 2018. He experienced flu like symptoms for about 5 days. The patient may not receive the second dose due to this experience.
This spontaneous report as received from a health professional refers to a 12 month old patient of unknown gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 24-NOV-2015, the patient was vaccinated with an improperly stored dose of VARIVAX lot #L024256, expiration date: 01-JUL-2017 (exact dose and route of administration were not reported). There was no adverse effect reported. Administered dose of vaccine experienced the temperature excursion of 20.3 degrees Fahrenheit for 72 hours. Data logger was involved. There were no previous excursions reported. This is one of several reports received from the same reporter. Additional information has been requested.
Swelling, redness, blistering with some weeping, warm to touch, some pain and itching at injection site where Tdap and Menveo were given. on 9/16/2015, area measured 1inch by 1inch and was red and warm to touch. On 9/17/2015, area measured 6inches long by 5inches wide with blistering and weeping at injection site. Area was cleaned and dressed with TAO, 2x2 gauze and wrapped loosely because of weeping from area. Physician prescribed oral steroids for patient. Follow up call made on 9/18/2015 and mother reported that area was improving. Another follow up call made on 9/21/2015 to parent and mother reported that area was completely healed now. Noted in patient chart that reaction took place and advised caution with next dose of vaccines.
patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication of the patient was not reported.  The reporter reported that because their facility had not been able to download the digital data logger, they had been put on hold by the State at the moment and cannot administer the Moderna COVID-19 vaccine to patients until an assessment by the state was made. There had been no power outages that would have impacted the Moderna vaccine. However, the reporter reiterated that because the facility was unable to download the digital data logger, this issue was treated as a temperature excursion. The reporter was unable to download the data logger for the months of December 2021, January 2022 and February 2022. The reporter was filling out a temperature excursion assessment with the State.  The reporter mentioned that the patient had been administered dose while the temperature excursion assessment was ongoing. The reporter also reported that, no adverse reactions were reported by the patient.  No treatment information was provided by the reporter.
Complained of sob and chest pain on the same day of his shot, but resolved on its own, later that night started with new-onset fever/chills, headaches, myalgias, and a new onset rash spreading from face to trunk, early lesions described as red papules and eventually dry up, no dermatomal distribution, spread throughout, not itchy, refers some tenderness/burning feeling upon palpation.  Only treatment received is Tylenol.
5 hours after vaccine had explosive diarrhea, 2 hours after that throat swollen and sore, tongue a bit swollen and fevers. The following day same symptoms but also coughing fits and sever exhaustion/fatigue. Today same symptoms but also vomiting and hives/rash. I also started feeling lightheaded about 30 minutes after the vaccine but that could also just be season allergies and sinus issues, still feeling lightheaded and dizzy.
Began with fatigue and nausea/stomach upset. This progressed all day and then 12/24/2020 late at night woke up in a sweat and noted a fever of 102F via oral thermometer.
Pt recvd MMR vax on 15OCT90; On 22OCT90 pt devel URI & reported that menstrual period was 2 days late;
I contracted COVID-19 in mid-December 2022. Symptoms included fever, muscle ache, sore throat, general malaise, brain fog, and sinus congestion. The day I tested positive, I took Paxlovid, which helped resolve the disease in five days. Three days after that, however, I had a relapse, but this time, it was more like a very bad cold or a mild flu. This relapse lasted another five days, and after that I was fine, albeit fatigued. No long COVID ensued.
Vaccinee was given a series of 3 Engerix-B vax on 5DEC89 lot no 585A4, 2JAN90 lot no 586A4, & 4JUN90 lot no 587A4; Serology testing on 22AUG90 showed that vaccinee failed to seroconvert.
Information has been received from a pharmacist concerning an unspecified patient of unknown age and gender. The patient's pertinent medical history and concurrent conditions were not informed. It was reported that on 19-OCT-2016 the patient was vaccinated with ZOSTAVAX 19400 PFU, lot # M032651, expiration date 15-JUN-2017, administered via intramuscular route instead subcutaneous route. Concomitant therapies were not informed. The pharmacist stated that no adverse effects were reported. No product quality complaint (PQC) was involved. Additional information has been requested.
Associate gave pediatric Pfizer dose instead of the adult Pfizer dose. Patient is coming back up to the office to receive the adult Pfizer dose per CDC guidelines.